Molecular docking studies of toluene dioxygenase led to the prediction that angular and lateral cisdihydroxylation of tricyclic arene and heteroarene substrates could occur. Biotransformations of biphenylene, dibenzofuran, carbazole and dibenzothiophene, using Pseudomonas putida UV4 whole cells expressing toluene dioxygenase, confirmed that both angular and lateral cisdihydroxylation had occurred in the predicted regioselective and stereoselective manner.
Introduction
Ring hydroxylating dioxygenase enzymes, having the ability to catalyse arene cisdihydroxylations, are available with a range of binding site capacities, able to accommodate both mono-and poly-cyclic arenes. [1a-f] Among dioxygenases with smaller active sites are benzoate dioxygenase (BZDO) which accepts benzoic acid substrates, and toluene dioxygenase (TDO), which generally accommodate only monocyclic and bicyclic arenes. Larger binding sites are found in naphthalene dioxygenase (NDO), which mostly accept only bicyclic and tricyclic arenes, and biphenyl dioxygenase (BPDO) which catalyse cisdihydroxylation of polycyclic arenes containing up to five fused rings. NDO and BPDO are largely unable to catalyse cis-dihydroxylation of monocyclic arenes, exceptions being larger biaryl substrates, e.g. 3phenylphenol 1a. [2] Dioxygenase enzymes BZDO, TDO, NDO and BPDO have all been employed in chemoenzymatic synthesis, but to date most arene cis-dihydrodiol metabolites, used as chiral synthons, have been formed with monocyclic substrates and TDO as biocatalyst. [1a-f] Several molecular docking studies of TDO with monocyclic aromatic substrates, have recently been used to successfully match the resulting in silico predictions with reported benzylic monohydroxylation and arene cis-dihydroxylation results. [3a-e] Thus, AutoDock 4.2 molecular docking studies, of substituted phenol and aniline substrates with TDO, led to predictions about: (a) their preferred orientations during cis-dihydroxylation and (b) the resulting regioselectivity and stereoselectivity. These expectations were later confirmed by experimental results. [3c,3e] This approach was applied to the TDO docking results obtained using 3-hydroxybiphenyl 1a as substrate, where the corresponding metabolites 2a and 3a were predicted to be the major and minor products respectively, resulting from lateral cisdihydroxylation. [2] Biotransformation (P. putida UV4 mutant strain expressing TDO) of substrate 1a, yielded metabolites (5S,6R)-2a and (2R,3S)-3a with the predicted regio-and stereo-chemistry (Scheme 1).
Scheme 1. cis-Dihydroxylation of 3-hydroxybiphenyl 1a
to give cis-diols 2a and 3a.
TDO-catalyzed regio-and stereo-selective cis-dihydroxylations of bicyclic arenes, (e.g. naphthalene) and heteroarenes (e.g. quinoline), predicted by AutoDock Vina molecular docking (unpublished data), matched with earlier experimental results. [1a-c,4] Similar TDO-catalyzed cis-dihydroxylations of tricyclic arenes and heteroarenes, to our knowledge, have not been reported. Thus, the current study, using the AutoDock Vina program, was undertaken to find out if: (i) the larger tricyclic arene substrates, e.g. biphenylene 1b, dibenzofuran 1c, carbazole 1e and dibenzothiophene 1d would be accommodated by the TDO active site, (ii) the experimental cis-dihydroxylation results, obtained using TDO and NDO enzymes expressed by mutant Pseudomonas strains, would match those predicted by the molecular docking results (Scheme 2) and (iii) supporting evidence could be obtained for the postulated role of transient metabolites leading to the formation of phenols and other metabolites from tricylic arenes and heteroarenes. Scheme 2. Dioxygenase (DO)-catalysed cisdihydroxylation of arenes 1b-1e to give cis-dihydrodiols 2b-2e, 3c-3e, 4c-4e, phenols 5c, 5e and sulfoxide 5d.
Results and Discussion
The biotransformation (P. putida UV4 whole cells, expressing TDO) of biphenylene 1b had resulted in cis-dihydroxylation at a ring junction (angular) bond to give only cis-dihydrodiol 2b. [5a,5b] Conversely, the biotransformation of tricyclic heteroarenes 1c-1e by mutant strains of P. putida 9816/11 and P. fluorescens TTC1(NCIMB 40605), both expressing NDO, resulted in lateral cisdihydroxylations to yield cis-diols 2c-2e. [6a-d] Molecular docking studies were conducted to compare with these reported biotransformation results and to predict if similar results would be found using TDO with potential substrates 1c-1e.
TDO docking of biphenylene 1b:
Prior to the earlier reports, using biphenylene and 1,2dihydrobenzocyclobutene as substrates, TDOcatalysed cis-hydroxylation at an angular position, in a substituted monocyclic or bicyclic arene substrate was unprecedented. [5a,5b] The cis-dihydroxylation (P. putida UV4) of biphenylene 1b was thus unusual, since the attack occurred exclusively at an angular bond (1,8b), to give (1S,8bR)-dihydrodiol 2b (66% isolated yield) as the only isolated metabolite (Scheme 2).
Biphenylene 1b, having two fused benzene rings and with four possible canonical (resonance) structures (4, 6, 8, 12), was classified as a tricyclic arene substrate with some anti-aromatic character (Figure 1 ). [7] Electron density is more localized within the biphenylene ring and the 4 (cyclobutadiene) resonance structure being disfavoured. Thus, its aromaticity was markedly reduced compared with the tricyclic arenes 1c-1e and was estimated as only 1.59 times that of benzene. [7] TDO-catalysed angular cis-dihydroxylation, to yield cis-dihydrodiol 2b, would therefore be more favoured by the 6, 8 and 12 canonical structures.
Using Autodock Vina, the energetically most favourable binding orientation of biphenylene 1b (-6.6 kcal·mol -1 , 1b1) within the active site of TDO is shown in Figure 2 . This orientation appeared to be mainly due to: (i) attractive interactions of the substrate with the orthogonal phenyl group of Phe-216 and with the imidazole group of His-222 (edgeto-face bonding) and (ii) the proximate hydrophobic amino acids . It would also result in an exclusive preference for angular rather than lateral cis-dihydroxylation and is matched by the isolation of the remarkably stable enantiopure cis-diol (1S, 8bR)-2b (> 98% ee), as the only detected metabolite using P. putida UV4. [5a,5b] The opposite enantiomer (1R,8bS)-2b was isolated later when biphenylene 1b was used as substrate for a different Pseudomonas strain (C250), expressing carbazole 1,9a-dioxygenase (CARD). [6b] These reports provide a very rare example of enantiocomplementarity during dioxygenasecatalysed formation of arene cis-dihydrodiols. The good agreement between the biotransformation result and in silico TDO binding orientation of biphenylene 1b provided an incentive to extend the docking of tricyclic heteroarenes 1c-1e, in the quest for further evidence of lateral or angular cis-dihydroxylation. 
(ii) TDO docking of dibenzofuran 1c:
Molecular docking of dibenzofuran 1c with TDO ( Figure 3 ) led to the prediction of two preferred orientations (1c1 and 1c2), which appeared to be very similar to the preferred orientation of biphenylene 1b ( Figure  2 ). ).
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Lateral cis-dihydroxylation was predicted to occur preferentially at the 1,2-bond, to yield the (1R,2S) enantiomer 2c, based on the higher binding energy (-5.7 kcal·mol -1 , 1c1) . This docking study of dibenzofuran 1c also predicted a less favoured alternative orientation, based on the lower binding energy (-5.0 kcal·mol -1 , 1c2). However, with closer proximity between the 4,4a-bond of substrate and dioxygen (3.2 Å) could result in angular docking, leading to the formation of a transient cis-dihydrodiol metabolite 4c, ring opening to a catechol and further biodegradation products. No docking evidence was found to predict lateral cis-dihydroxylation (using TDO) at the 3,4-bond of substrate 1c, to yield cisdihydrodiol 3c. This was presumed to be due to the larger distance of the 3,4-bond from the bound dioxygen molecule.
Biotransformations of dibenzofuran 1c
(catalyzed by ring hydroxylating dioxygenases with larger active sites compared to TDO) yielded both cis-dihydrodiols 2c and 3c along with other metabolites, which were consistent with the initial formation of transient angular cis-dihydrodiol 4c. [8a-8c] Both NDO-catalysed biotransformations (P. putida 9816-11 and P. fluorescens TTC1 mutant strains) of dibenzofuran 1c gave metabolites cis-dihydrodiol 2c (60%) and cis-dihydrodiol 3c (40%). [6c,6d] Recent computational modelling studies of NDO with arene substrates have been reported. [9a,9b] The current docking study of dibenzofuran 1c with NDO, using Autodock Vina, produced two orientations leading to the prediction that cisdihydroxylation and higher binding energies would result in the formation of metabolites (1R,2S)-2c ( Figure 4 , 1c3, -8.8 kcal·mol -1 ) and (3S,4S)-3c ( Figure  4 , 1c4, -8.5 kcal·mol -1 ). The predicted relative ratio and absolute configurations of these major and minor metabolites were in accord with the isolated bioproducts 2c and 3c. [6c,6d] The primary interactions leading to this orientation of substrate 1c (Figure 3, 1c1 and 1c2) were very similar to those found with biphenylene 1b (Figure 2 ). Thus, one benzene ring was observed to interact with the proximate hydrophobic amino acids . Edge-to face interactions between phenyl rings have been widely reported in reviews, but much less information is available on similar interactions between phenyl groups and five membered heterocyclic rings. [10a] Recently, evidence for the edge-to-face interactions between benzene and furan or thiophene rings has been reported. [10b, 10c] To date little evidence for edge-to-face bonding between benzene and imidazole rings appears to have been been reported. However, the preferred binding orientations of dibenzofuran 1c with TDO shown in Figure 3 , are consistent with edge-to-face interactions between the benzene ring, closer to dioxygen and the phenyl ring of Phe-216, and also with the imidazole ring of His-222.
The differences in stereo-and regioselectivity between TDO and NDO can be explained by the differing volumes of their active sites. The overall number and distances between amino acids is larger in NDO (ca. 20 amino acids, 11-15 Å) than in TDO (17 amino acids, ca. 8-13 Å) ( Figure SI 1 ). Furthermore, CASTp calculations suggested that the volume of the NDO active site (92.987) is 130% larger than the TDO active site (40.140). [9c] The larger capacity of the NDO active site, would allow both binding orientations to facilitate formation of the isolated cis-dihydrodiols 2c and 3c while the smaller dimensions of the TDO active site, would favour only the formation of cis-dihydrodiol 2c.
(iii) TDO-docking of carbazole 1e:
The hydrophobic and edge-to-face interactions and preferred TDO binding orientation of carbazole 1e ( Figure 5 , 1e1, -5.3 kcal·mol -1 ) are very similar to that shown for the predicted lateral cis-dihydroxylation of dibenzofuran 1c (Figure 3 , 1c1, -5.7 kcal·mol -1 ) and would lead to the formation of (4R,3S)-cisdihydrodiol 2e. NDO-catalyzed biotransformation of carbazole 1e had been reported to give phenol 5e as the only isolated metabolite. [6a] NDO-docking orientations are shown in Figure SI 2. It was postulated that phenol 5e could result from dehydration of the unstable metabolite cisdihydrodiol 2e. Although a lower binding energy was found for this TDO docking orientation (1e2, -4.6 kcal·mol -1 ), the shorter distances between proximate dioxygen and 3,4-bond of substrate (3.1 Å) could facilitate the angular cis-dihydroxylation of carbazole 1e, yielding the transient metabolite 4e with a (1S,9aR) configuration. The formation of metabolite 4e was proposed during the CARDO-catalysed biotransformation of carbazole 1e; it was assumed to undergo further metabolism and ring opening, to yield a range of products including anthranilic acid. [8a, 8d] 10.1002/adsc.201900147
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(iv) TDO docking of dibenzothiophene 1d:
Docking of dibenzothiophene 1d with TDO ( Figure  6 ) showed one favoured orientation (1d1, -5.0 kcal·mol -1 ) that was similar to those found using biphenylene 1b (Figure 2 ), dibenzofuran 1c ( Figure  3 ) and carbazole 1e ( Figure 5 ). These orientations were consistent with lateral cis-dihydroxylation occurring, preferentially, at the 1,2-bond to form the major metabolite (1R,2S)-2d enantiomer. The sulfur atom in dibenzothiophene 1d was closer to the nearest oxygen atom (3.3 Å) within the TDO active site ( Figure 6 , 1d2) compared with NDO (4.0 Å, Figure SI 3, 1d3) leading to the prediction that sulfoxidation might occur more readily with TDO. However, the low free binding energy (1d2, -2.9 kcal·mol -1 ) associated with this orientation would not facilitate the formation of sulfoxide 5d or the transient angular cis-dihydrodiol 4d. It is noteworthy that while transient angular cis-diols 4c and 4e were postulated as initially formed intermediates during CARDO-catalysed dihydroxylation of dibenzofuran 1c and carbazole 1e, formation of the corresponding angular cis-diol 4d of dibenzothiophene 1d was not proposed. [8a] NDO docking of dibenzothiophene 1d ( Figure SI 3) led to the prediction that cisdihydrodiols 2d and 3d would be equally preferred metabolites based on binding energies (1d3, -8.5 kcal·mol -1 ; 1d4, -8.5 kcal·mol -1 ). In practice, cis- 
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Advanced Synthesis & Catalysis dihydrodiol 2d was the main metabolite (85-95%), along with cis-dihydrodiol 3d (<5%) and sulfoxide 5d (<15%) as minor products from the NDOcatalysed oxidation of dibenzothiophene 1. [6c,6d] 1d1 1d2 Figure 6 : In silico docking orientations of dibenzothiophene 1d with TDO. 1d1: -5.0 kcal·mol -1 ; 1d2: -2.9 kcal·mol -1 .
(v) TDO-catalyzed biotransformation of dibenzofuran 1c: Medium-scale biotransformations (P.putida UV4) of dibenzofuran 1c (400-500 mg/L) were conducted in 2 litre baffled flasks, employing a slight modification of reported conditions. [2,3c,5b] At pH below 7.5, very little evidence of cis-dihydrodiol 2c formation was observed (Scheme 3). Maintaining the pH within the range 7.5-8.5 significantly reduced the dehydration of metabolite 2c, to yield mainly phenol 5c and enabled yields of up to 90% (LC-MS analysis). Metabolite 2c was initially isolated in an average yield of ca. 40%, but using an extended biotransformation period (48 h) at pH 8.0 and a careful workup procedure an optimal isolated yield of 85% was achieved.
During earlier NDO-catalysed biotransformations of dibenzofuran 1c at pH 7.0-7.3, a range of metabolites was formed. [6b,6d] Among the mixture, that proved difficult to separate, were cisdihydrodiols 2c and 3c and the corresponding phenols, resulting from their partial dehydration. In contrast to the very stable cis-diol metabolite 2b, formed from biphenylene 1b, cis-dihydrodiol 2c was found to be more susceptible to dehydration at ca. pH 7, yielding mainly 2-hydroxydibenzofuran 5c and 1hydroxydibenzofuran 8c as a very minor product (Scheme 3). cis-Dihydrodiol 2c was the only metabolite detected using E. coli TOP10109 (pCL-41) and E. coli 1/210LK recombinant cells, both expressing TDO. While lower yields were obtained with these recombinant strains, they provided further evidence that TDO was the biocatalyst responsible for the cis-dihydroxylation of this tricyclic arene.
Neither enantiopurity values nor absolute configurations were established for metabolites isolated during the NDO-catalysed (P. fluorescens TTC1) biotransformation studies of dibenzofuran 1c. [6d] be very useful in assigning both ee values and absolute configurations to most arene cisdihydrodiols. [11a] cis-Dihydrodiol metabolite 2c isolated during the current study, was hydrogenated (Pd/C, MeOH) to yield cis-tetrahydrodiol 6c (90 % yield). Reaction with (+) and (-)-MTPA chloride gave the corresponding diastereomeric (+)-7c (R) diMTPA ester-and (-)-7c (S) -diMTPA ester (Scheme 3). NMR analysis of the diMTPA esters showed that the metabolite was enantiopure. This method had been used earlier to determine both ee values and absolute configurations of other cis-diol metabolites, derived from polycyclic arenes. [11b] The diMTPA method showed that the cis-dihydrodiol 2c ([α]D +217) was enantiopure (>98% ee) and was assigned a (1R,2S) configuration.
As part of a preliminary study of the potential of cisdihydrodiol 2c as a chiral synthon in natural product synthesis, it was considered appropriate to establish its absolute configuration by X-ray crystallography. cis-Diol epoxide derivative 10c was synthesized in two steps from cis-dihydrodiol 2c, via trans bromohydrin intermediate 9c (Scheme 3). X-ray crystallographic analysis of a suitable crystal (from Et2O-hexane) of epoxide 10c established its absolute configuration as (1aS,2R,8R,8aR) ( Figure 7) . The (1R,2S) configuration for cis-dihydrodiol 2c, presumed by the consistent trends in chemical shifts of specific signals in NMR spectra of the MPBA and diMTPA derivatives, was therefore confirmed. [6c,11a,11b] cis-Dihydrodiol 2c was initially detected by reverse phase LC-MS analysis of the biotransformation supernatant aqueous solution and was identified by a large peak eluting after 18 min. In some of the repeat biotransformations of dibenzofuran 1c, evidence of a very minor metabolite eluting after 12 min., with a mass of [M+NH4 + ] = 236.09150, was also observed (SI: Figure 17 ). Since 2-hydroxydibenzofuran 5c is readily produced by partial decomposition of cis-dihydrodiol 2c, during the biotransformation, the possibility that this very minor bioproduct could be 8-hydroxydibenzofuran-1,2-diol 11c (calculated mass: 236.09173), was considered (Scheme 4). Biotransformation of phenol 5c, to yield the possible metabolite 11c, resulted in a significant proportion of the substrate being recovered, however, LC-MS analysis of the supernatant again detected the presence of this metabolite in very low yield.
The 1 H NMR (400 MHz) spectrum of a late eluting impure fraction, collected during the purification (column chromatography) of the crude biotransformed material obtained from dibenzofuran 1c, showed most of the characteristic cis-dihydrodiol signals:  = 4.88 (1H, d, J = 6.9, 2.5 Hz, H-1), 5.96 (1H, ddd, J = 10.3, 2.5, 1.3 Hz, H-4), 6.43 (1H, dd, J = 10.0, 2.8 Hz, H-3), which were close to but distinct from those observed for the major cis-dihydrodiol 2c. Attempts to purify it further by PLC resulted in its decomposition. In an effort to obtain more evidence for the formation of hydroxydiol 11c, molecular docking of phenol 5c with TDO was conducted ( Figure SI 4) . The results indicated a preferred orientation that would lead to the formation of phenolic cis-dihydrodiol 11c with an identical absolute configuration to that found in dibenzofuran cis-dihydrodiol 2c, but with a low free binding energy (-3.1 kcal·mol -1 ). Based on the limited LC-MS and NMR data available an molecular docking 10.1002/adsc.201900147
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This article is protected by copyright. All rights reserved. evidence, the possibility that biotransformation of dibenzofuran 1c can occasionally yield both cisdihydrodiols 2c and 11c, via the metabolic pathway shown in Scheme 4, cannot be excluded. The TDOcatalysed formation of cis-dihydrodiols from monocyclic phenols, e.g. compounds 2a and 3a from substrate 1a was established earlier. [2, 3c, 3e] (vi) TDO-catalyzed biotransformation of carbazole 1e: Biotransformations of carbazole 1e had been reported using, P. putida 9816/11 (NDO source), E. coli JM109(pKK223-3) (NDO source) and Sphingobium yaniokuyae B8/36 (BPDO source). [6a] No metabolites were identified from the attempted biotransformation of carbazole 1e using P. putida F39/D (TDO source), but NDO-and BPDOcatalysed oxidations resulted in the formation of a single metabolite, which was identified as 3hydroxycarbazole 5e. [6a] While the possibility of a direct enzymatic monooxygenation was not excluded, an alternative lateral cis-dihydroxylation mechanism was proposed, through the formation of an unstable cis-dihydrodiol 2e, followed by its spontaneous dehydration (Scheme 5). A transient angular cisdihydrodiol metabolite 4e, resulting from a CARDOcatalysed (Pseudomonas sp.CA10) cisdihydroxylation of carbazole 1e was postulated to account for the formation of anthranilic acid 8e as a metabolite formed via catechol 6e and ketocarboxylic acid 7e intermediates. [8a] As expected, repeat biotransformations (P. putida UV4) of carbazole 1e showed no evidence of the predicted transient cis-dihydrodiol 2e. GC-MS analysis of the crude extract, did however indicate that anthranilic acid 8e was the major identifiable metabolite. 3-Hydroxycarbazole 5e was also detected but only as a very minor dehydration product (SI: Figure 16 ), presumably derived from the unstable cisdihydrodiol 2e. Extraction (EtOAc) of bioproducts of carbazole 1e, followed by PLC purification, yielded a crystalline product whose NMR spectrum confirmed that the major metabolite was anthranilic acid 8e. The isolation of bioproduct 8e and detection of 3hydroxycarbazole 5e (Scheme 5), were consistent with the predicted formation of the corresponding transient cis-diols 2e and 4e, via the other undetected intermediates 6e and 7e (SI: Figure 2, 1e1, 2e2) . The isolation of cis-diol 2b and anthranilic acid 8e from biotransformations of biphenylene 1b and carbazole 1e respectively, provided support for in silicopredicted angular cis-dihydroxylations being catalysed by TDO. , 2d, 3d and sulfoxide 5d were identified as the major NDOcatalysed metabolites of dibenzothiophene 1d, using P. putida 9816-11, E. coli JM109(DE3)(pDTG141) and P. fluorescens TTC1 cells. The enantiopurity (>95%) of cis-diol 2d was determined by formation of chiral boronate derivatives. [6c,6d] While neither ee value nor absolute configuration of the minor cis-dihydrodiol metabolite 3d (>5% yield) was reported, results from the NDO docking study of dibenzothiophene 1d (SI Figure: 3  1d3, 1d4) suggest that metabolite 3d should be enantiopure and have a (3S,4S) configuration. [6c,6d] A small-scale (50 mg) biotransformation (P. putida UV4) of dibenzothiophene 1d, under the optimized conditions developed for dibenzofuran 1c, was carried out. LC-MS analysis of the aqueous supernatant showed the presence of a single metabolite, which was identified as cis-dihydrodiol 2d at a retention time of 19.1 min. The limited quantity of metabolite 2d available, following PLC purification, was just sufficient to record 1 H NMR and 13 C NMR spectra, high resolution MS data and a crude optical rotation value. Comparison with the literature data, based on the consistent trend in chemical shifts observed for chiral boronates formed using (R) and (S) MPBA, was used to assign the (1R,2S) absolute configuration to metabolite (+)-cis-dihydrodiol 2d. [6c] As this method, provided the correct absolute configuration to the dibenzofuran cis-dihydrodiol (+)-2c during the current study, the (+)-(1R,2S)-dihydrodiol 2d assignment it was again presumed to be correct.
(vii) TDO-catalyzed biotransformation of dibenzothiophene 1d: cis-Dihydrodiols
cis-Dihydrodiol 2d was isolated in an unoptimized yield of 16% using TDO while a yield of 44% was reported using NDO. [6c] It was noteworthy that a much higher yield of cis-dihydrodiol 2c (>85%) was obtained during the current programme. The increased water solubility of the dibenzofuran 1c (3.1 mg L -1 ) compared with dibenzothiophene 1d (1.5 mg L -1 ) could be an important factor in the higher yield of metabolite 2c. Furthermore, as cis-dihydrodiol 2d was the only detected metabolite, the task of separation of metabolites encountered using NDO was not required. [6c,6d] The predicted stereochemistry from molecular docking of dibenzothiophene 1d with TDO was in agreement with the assigned absolute configuration of the cis-dihydrodiol 2d ( Figure 5 ).
Dioxygenase-catalysed sulfoxidation of thiophenes was reported using both TDO and NDO enzymes. [12] Sulfoxide 5d was also found as a minor metabolite of dibenzothiophene 1d in one of the studies using NDO. [6c,6d] The very low free binding energy associated with the preferred orientation of dibenzothiophene 1d with TDO ( Figure 6, 1d2 ) , may be an important factor in sulfoxide 5d not being detected during the TDO-catalyzed biotransformation.
Several reasons could account for in silicopredicted metabolites not being observed experimentally. These include product instability due to decomposition, further metabolisation, alternative oxidation pathways, toxicity and water-solubility. In the case of TDO, the structure and physical properties of the substrate, its free binding energy and proximity to dioxygen within the active site can affect both the binding and arene cis-dihydroxylation, rendering the lateral or angular bond more reactive.
Conclusion
Application of the molecular docking program to the TDO-catalysed cis-dihydroxylation of the tricyclic arene substrates (1b-1e), led to the prediction of preferred structures and absolute configurations of isolated lateral (2c, 2d) and angular (2b) cis-dihydrodiols and transient cis- dihydrodiols  (2e, 4e) . In silico predicted results from TDO-and NDO-catalysed cis-dihydroxylation of substrates 1c-1e, were compared with literature results obtained using NDO and new experimental results obtained using TDO. The P. putida UV4 strain expressing TDO, was selected for biotransformations to confirm the Scheme 6: Structures of secondary metabolites 3f, 4f, 3g,  4g, 13c and 14c obtained by chemoenzymatic synthesis  from cis-dihydrodiol metabolites 2f, 2g, 2c and tricyclic  arene substrates 1f, 1g and 1c. Autodock Vina docking predictions. This resulted in the isolation of the relatively stable cis-dihydrodiols 2b, 2c and 2d, and identification of metabolites 5e and 8e, derived from the unstable carbazole cis-diols 10.1002/adsc.201900147 
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Advanced Synthesis & Catalysis 2e and 4e respectively. The direct formation of stable angular cis-diol 2b, and anthranilic acid 8e, via the unstable angular cis-diol 4e, were in accord with in silico predictions. These results also provide support for the view that TDO could be responsible for both lateral and angular cis-dihydroxylation of tricyclic arenes.
The TDO-catalysed biotransformation of dibenzofuran 1c was optimized, to obtain cisdihydrodiol 2c as the main metabolite in enantiopure form and good yield. The (1R,2S) absolute configuration of cis-dihydrodiol 2c was confirmed by a combination of chemoenzymatic synthesis with NMR analysis of chiral boronate and diMTPA esters and X-ray crystallographic analysis of the derived tricyclic (1aS,2R,8R,8aR)-diol epoxide 9c.
To date nearly all cis-dihydrodiols used in the chemoenzymatic synthesis of natural products have been derived from monocyclic arenes. [1f] The BPDOcatalysed cis-dihydroxylation of acridine (1f) and dictamnine (1g) was among the few examples where tricyclic arene cis-dihydrodiols (2f and 2g) were used in the chemoenzymatic synthesis of secondary metabolites including alkaloids (Scheme 6). [13] The bacterial cis-dihydrodiol metabolites 2f and 2g were used in the chemoenzymatic synthesis of (i) mammalian metabolites, e.g. arene oxide intermediate 3f and isolated trans-dihydrodiol 4f and (ii) plant metabolites, e.g. intermediate arene oxide 3g and isolated furoquinoline alkaloid 4g. The chemoenzymatic synthesis of the tricyclic fungal metabolites, e.g. Ribisin A 13c and Ribisin B 14c from a monocyclic bacterial cis-dihydrodiol metabolite of bromobenzene was reported. [14a-c] Utilizing tricyclic cis-dihydrodiol 2c as a chiral synthon, the chemoenzymatic synthesis of Ribisins 13c and 14c, is currently in progress.
Experimental Section
NMR spectra were recorded on Bruker Avance 400, General Electric QE-500, and Bruker AV-600 instruments. Chemical shifts ( ) are reported in ppm relative to SiMe4 and coupling constants (J) are given in Hertz (Hz). Optical rotations ([α]D) measurements were carried out on a Perkin-Elmer 214 polarimeter. LC-TOF-MS analyses were conducted on an Agilent 1100 series HPLC coupled to an Agilent 6510 Q-TOF and a reverse phase column (Agilent Eclipse Plus C18, 5 mm, 150 x 2.1 mm). Mass spectra (ES) were recorded on an LCT Premier Mass Spectrometer. Accurate molecular weights were obtained by the peak matching method, using heptacosafluorotributylamine as the standard reference and were accurate to within ±5x10 -6 a.m.u. Melting points were recorded in degrees Celsius using a Stuart SMP10 melting point apparatus. Merck Kieselgel 60F254 analytical plates were used for TLC analyses. Preparative layer chromatography (PLC) separations of metabolites were carried out on glass plates (20 cm x 20 cm) coated with Merck Keiselgel PF254/366 silica gel (21 g silica gel in 62 mL water).
Molecular Docking and in silico analysis
The protein models were obtained from the protein data bank. TDO pdb id: 3en1; NDO pdb id: 1o7n. The crystal structure of TDO does not contain bound dioxygen. Dioxygen was inserted into the 3en1 model by superimposing the iron centre of NDO, including the aspartate and the two histidine residues, onto the iron centre of TDO, using the "super" function of PyMOL (The PyMOL Molecular Graphics System, Version 2.2.0 Schrödinger, LLC.). The dioxygen was extracted from the superposition and combined with the 3en1 model.
Molecular docking was performed using the AutoDock Vina suite, version 1.1.2. [4] The docking site was set to include all amino acids within 6 Å of the substrate. TDO: center_x = 46.46, center_y = 120.49, center_z = 201.877; size_x = site_y = size_z = 16. NDO: center_x = 13.375, center_y = 49.781, center_z = 82.071; size_x = 20, size_y = 18, size_z = 18. All docking was performed with an exhaustiveness of 100. Autodock Vina automatically grouped similar orientations and produced each result with a respective calculated binding energy. Each docking yielded several possible orientations, which were examined critically. The orientations were then examined for their viability as a substrate based on their calculated binding energy, orientation and interaction/distance to the nearest residues.
The volume of the active site was calculated using the Computed Atlas of Surface Topography of proteins (CASTp) 3.0.[ 9c] Submission of the whole proteins resulted in calculated binding pockets larger than intended. Therefore, the amino acids and iron centre of the active site were submitted as a separate file.
Job IDs: NDO full: j_5c76b7f48839b (active site: pocket 3) NDO active site with water: j_5c76becff050b NDO active site without water: j_5c76bea6a2319 TDO full: j_5c6d8d0808b18 (active site: pocker 6) TDO active site: j_5c77a83860d0a
Microbiological Methods
All biotransformations were performed using P. putida UV4 whole cells, unless mentioned otherwise. The P. putida UV4 bacteria were initially streaked on Luria-Bertani medium (LB) plates and incubated for 24 h at 30ºC. Individual colonies were then transferred to MSM plates containing indole (0.0012% w/v 1 mM). Single colonies were transferred to two minimal salt medium (MSM) agar plates with 0.2% sodium pyruvate, one containing 1 mM indole. Colonies on the indole containing plate were visually selected for activity after 24 h of incubation at 30ºC, based on indigo (blue colour) being produced.
Cultures grown on the MSM plates were consistently checked for TDO activity and absence of dehydrogenase activity, using a 100 mL MSM culture, and 50 µL of chlorobenzene. Formation of the cis-dihydrodiol metabolite from chlorobenzene was followed by measuring the UV absorbance at 295 nm.
Biotransformations were carried out using MSM cultures (500 mL, pH 7.5), containing 10 g/L glucose, and were inoculated in 2000 mL baffled Erlenmeyer flasks with an active colony from the MSM plate not containing indole. The cultures were grown overnight by shaking at 140 rpm, 30 o C. The tricyclic arenes (500 mg/L) and carbon sources (4 g/L) were added to each 500 mL of culture medium in 2 L baffled shake flasks, which were incubated at 30 o C, on an orbital shaker (140 rpm) for 24 -48 h and maintaining the pH at 8. Samples were taken every 24 h and immediately frozen for LC-MS analysis. The crude biomixture was centrifuged (7000 rpm, 15 min, small scale) and the aqueous supernatant solution was then decanted off. The aqueous solution was concentrated in vacuo, maintaining the water bath temperature at 40ºC. The residue was extracted with ethyl acetate (3 x 100 mL) and concentrated in vacuo to yield the crude products. 1,2-dihydrodibenzofuran-1,2-diol 2c [6c,6d] cis-Dihydrodiol 2c was isolated as a metabolite from a biotransformation of dibenzofuran 1c (250 mg, 1.49 mmol) by extraction (3 x 100 mL EtOAc). The extract was concentrated in vacuo to give metabolite 2c as a white solid (250 mg, 84%); m. p. 96-98C (EtOAc / hexane); Rf 4.96 (1H, d, J = 6.3 Hz, 1-H), 6.05 (1H, ddd, J = 10.0, 2.5, 0.7 Hz, 6.51 (1H, dd, J = 10.0, 2.3 Hz, 7.27 (2H, m, 7.62 (1H, m, 7.45 (1H, m, ; 13 C NMR (100 MHz, CDCl3):  = 155. 1, 152.0, 134.3, 126.5, 124.6, 123.6, 119.2, 117.4, 113.5, 111.7, 70.8, 65.1; LRMS (EI): m/z = 202 (26), 184 (100) . (1R,2S)-1,2-Dihydroxy-1,2,3,4 
Biotransformation of dibenzofuran 1c to give (1R,2S)-
-tetrahydrodibenzofuran 6c
A solution of cis-dihydrodiol metabolite 2c (100 mg, 5 mmol), in MeOH (15 mL 4, 155.2, 127.3, 123.9, 122.9, 118.9, 113.7, 111.1, 69.4, 68.8, 26.2, 21.2 (1R,2S)-1,2-Dihydrodibenzothiophene-1,2-diol 2d [6c,6d] cis-Diol 2d was isolated as a metabolite from a small-scale biotransformation of dibenzothiophene 1d (50 mg, 0.27 mmol) by extraction (3 x 100 mL EtOAc). The extract was concentrated in vacuo and the concentrate purified by PLC to give cis-diol 2d as a white solid (9.4 mg, 16%). Rf 7, 137.9, 135.8, 132.2, 129.2, 125.0, 124.7, 122.8, 121.4, 120.7, 70.6, 65.5 .
Biotransformation of dibenzothiophene 1d to give
Biotransformation of carbazole 1e to give anthranilic acid 8e and 2-hydroxycarbazole 5e [6a]
A small scale biotransformation of carbazole 1e (50 mg, 0.30 mmol) followed by EtOAc extraction of the aqueous supernatant on concentration gave the crude bioproduct mixture. GC-MS analysis (Agilent Technologies Ultra 2 12 m x 0.2 mm i.d. x 0.33 μm column) of the crude extract showed the presence of a major peak (9.5 min.) which was identified as that of anthranilic acid 8e (MW 137), by comparison with an authentic standard and also formation 10.1002/adsc.201900147
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This article is protected by copyright. All rights reserved. of the trimethylsilyl derivative. A very minor peak (16.6 min.) was identified as 3-hydroxy carbazole 5e (MW 183: m/z 183, 154, 127, 92, 77) ; its mass fragmentation pattern was identical to that reported in the literature. PLC purification (35% EtOAc in hexane, Rf = 0.25) of the crude mixture yielded (6.4 mg) pure crystalline anthranilic acid 8e. (1R,2R,3S,4S)-3-Bromo-1,2,3,4tetrahydrodibenzo[b,d]furan-1,2,4-triol 9c To a solution cis-dihydrodiol 2c (27 mg, 0.13 mmol) in THF-H2O (4:1, 3 mL) was added NBS (40 mg, 0.22 mmol) and the mixture was stirred overnight at room temperature. After addition of Na2S2O5 (10 mg), the mixture was stirred for 10 min., diluted with EtOAc (10 mL) and washed with brine (5 mL). The organic phase was separated, dried (MgSO4), and concentrated in vacuo. The crude material, was purified by flash column chromatography (silica gel, 30% EtOAc in hexane) to give bromohydrin 9c as a purple solid (27 mg, 68%); Rf = 0.22 (40% EtOAc in hexane); 3, 154.3, 128.1, 126.2, 124.4, 121.2, 116.7, 112.6, 73.5, 71.6, 65.2, 59.1 .   (1aS,2R,8R,8aR)-1a,2,8, 
8a-Tetrahydrobenzo[b]oxireno[2,3-f]benzofuran-2,8-diol 10c
Sodium methoxide (10 mg, 185 µmol) was added to a solution of bromohydrin 9c (20 mg, 67 µmol) in THF (3 mL) and the reaction mixture was stirred (3 h) at room temperature. The salts were removed by gravity filtration and the filtrate was concentrated in vacuo. Purification of the residue by flash column chromatography (silica gel, 50% EtOAc in hexane) gave epoxide 10c as a white crystalline solid (8 mg, 55%); Rf = 0. = 157.0, 150.8, 128.4, 125.4, 123.8, 122.0, 114.3, 112.1, 64.9, 63.5, 57.6, 56.9 ; IR (KBr) νmax/cm -1 3995, 2956, 2927, 2853, 1781, 1596, 1354, 1181, 1228, 1051. X-ray crystallographical analysis for 10c [15] Crystal data collection was performed on a Rigaku Single Crystal X-ray diffractometer, equipped with cryostat. Measurements were carried out at 100 K using a Cu-Κα, monochromator, λ = 1.54184 Å. Using Olex2, the structure was solved with the ShelXT structure solution program using Intrinsic Phasing and further refined with the ShelXL refinement package using least squares minimisation.
Crystal Data: C12H10O4, M = 218.2: orthorhombic, space group P212121 (no.19), a =5.56920(10), b = 7.35790(10), c = 23.3201(5) Å, V = 955.60(3) Å 3 , Z = 4, T = 100.0(2) K, Dcalc = 1.361 g/cm 3 , 10979 reflections measured (12.616° ≤ 2Θ ≤ 144.426°), 1878 unique (Rint = 0.0236, Rsigma = 0.0138) which were used in all calculations. The final R1 was 0.0395 (I > 2σ(I)) and wR2 was 0.0962 (all data).
